These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26256294)

  • 21. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
    Mennini FS; Bini C; Marcellusi A; Rinaldi A; Franco E
    Hum Vaccin Immunother; 2018; 14(8):1867-1873. PubMed ID: 29708843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the health economic consequences of quadrivalent influenza vaccination.
    de Boer PT; van Maanen BM; Damm O; Ultsch B; Dolk FCK; Crépey P; Pitman R; Wilschut JC; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):249-265. PubMed ID: 28613092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.
    McKeage K
    Drugs; 2013 Sep; 73(14):1587-94. PubMed ID: 24022123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K
    Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
    Heikkinen T; Ikonen N; Ziegler T
    Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Chiu SS; Feng S; Chan KH; Lo JY; Chan EL; So LY; Cowling BJ; Peiris JS
    Vaccine; 2016 Apr; 34(19):2164-9. PubMed ID: 27013437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine for prevention of mild and moderate-to-severe influenza in children.
    Jain VK; Rivera L; Zaman K; Espos RA; Sirivichayakul C; Quiambao BP; Rivera-Medina DM; Kerdpanich P; Ceyhan M; Dinleyici EC; Cravioto A; Yunus M; Chanthavanich P; Limkittikul K; Kurugol Z; Alhan E; Caplanusi A; Durviaux S; Boutet P; Ofori-Anyinam O; Chandrasekaran V; Dbaibo G; Innis BL
    N Engl J Med; 2013 Dec; 369(26):2481-91. PubMed ID: 24328444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey.
    Amiche A; Tanriover MD; Bellier L; Ugur B; Akin L
    Value Health Reg Issues; 2021 Sep; 25():15-22. PubMed ID: 33485248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
    Ray R; Dos Santos G; Buck PO; Claeys C; Matias G; Innis BL; Bekkat-Berkani R
    Hum Vaccin Immunother; 2017 Jul; 13(7):1640-1652. PubMed ID: 28532276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and control of influenza and dengue through vaccine development.
    Greenberg DP; Robertson CA; Gordon DM
    Pediatr Ann; 2013 Aug; 42(8):172-7. PubMed ID: 23910031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
    You JH; Ming WK; Chan PK
    BMC Infect Dis; 2014 Nov; 14():618. PubMed ID: 25420713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis.
    Pitrelli A
    J Prev Med Hyg; 2016; 57(1):E34-40. PubMed ID: 27346938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G; Gregg M; Poulsen Nautrup B
    J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010.
    Chan PK; Chan MC; Cheung JL; Lee N; Leung TF; Yeung AC; Wong MC; Ngai KL; Nelson EA; Hui DS
    Clin Infect Dis; 2013 Mar; 56(5):677-84. PubMed ID: 23074315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
    Uhart M; Bricout H; Clay E; Largeron N
    Hum Vaccin Immunother; 2016 Sep; 12(9):2259-68. PubMed ID: 27166916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study.
    Shasha D; Valinsky L; Hershkowitz Sikron F; Glatman-Freedman A; Mandelboim M; Toledano A; Paran Y; Ben-Ami R; Goldman D
    Clin Microbiol Infect; 2020 Jan; 26(1):101-106. PubMed ID: 31108229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly.
    Mullikin M; Tan L; Jansen JP; Van Ranst M; Farkas N; Petri E
    Infect Dis Ther; 2015 Dec; 4(4):459-87. PubMed ID: 26350238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.